In particular, DAPT treatment reduced the CSC population by targeting the Notch1/HES1 axis that is often upregulated in HNSCC and is associated with higher expression of self-renewal markers such as CD44, Sox2, Slug, and ALDH1 [408]. Here, NOTCH1 is linked to head and neck squamous cell carcinoma.